Tesamorelin 10mg — double-dose format for full-course research protocols. FDA-approved GHRH analogue that selectively stimulates pituitary GH without affecting cortisol or prolactin.
- FDA-approved profile — Egrifta® approved for HIV-associated lipodystrophy.
- Selective GH stimulation — no cortisol or prolactin interference.
- Visceral fat reduction — −15% to −18% trunk fat in 26-week clinical trials.
- Cognitive research applications — GH/IGF-1 axis stimulation associated with improved cognitive function in human studies.
⚠️ For research use only. Not for human or animal consumption. Store at −20°C. Reconstitute with Bacteriostatic Water.
Reviews
There are no reviews yet.